ProCE Banner Activity

Antibody–Drug Conjugates Targeting Cell Surface Receptors in TNBC

Slideset Download
Download these slides from a live webinar to gain expert insight into the latest evidence on antibody-drug conjugates and their evolving role in TNBC

Released: May 11, 2021

Expiration: May 10, 2022

No longer available for credit.

Share

Faculty

Ian E. Krop

Ian E. Krop, MD, PhD

Associate Professor of Medicine
Harvard Medical School
Associate Chief, Division of Breast Oncology
Breast Oncology Program
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.

Faculty Disclosure

Primary Author

Ian E. Krop, MD, PhD

Associate Professor of Medicine
Harvard Medical School
Associate Chief, Division of Breast Oncology
Breast Oncology Program
Dana-Farber Cancer Institute
Boston, Massachusetts